Cipher CIP-Tramadol ER Will Not Need Alcohol Interaction Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Cipher no longer needs to complete a Phase I trial to investigate a potential interaction between the once-daily sustained-release pain medication CIP-tramadol ER and high levels of alcohol, the firm said June 15
You may also be interested in...
CIP-Tramadol Has April 2007 User Fee Date
Cipher NDA submission for the sustained-release pain medication includes data from five Phase III studies.
CIP-Tramadol Has April 2007 User Fee Date
Cipher NDA submission for the sustained-release pain medication includes data from five Phase III studies.
Cipher Receives “Approvable” Letter For CIP-Isotretinoin
FDA letter appears to resolve questions about the appropriate pathway for the acne medication.